Abstract:Background Glaucoma filtering surgery (GFS) is the most common procedure performed in the treatment of glaucoma. Although antiscarring agents help prevent postsurgical scarring and improve glaucoma surgical outcomes, they may be associated with an increased incidence of severe and potentially blinding complications. Poly(DL-lactide-co-glycolide) (PDLLA/GA) is a bioresorbable polymer, which can be prepared with a large range of physical, mechanical, and biological properties and has been widely used in medicine, including as an absorbable suture and a drug carrier and especially as a scaffold in tissue engineering. This study aimed to evaluate the effect of PDLLA/GA on scar formation after glaucoma filtration surgery (GFS).Methods Forty-eight New Zealand white rabbits were divided into two groups randomly and GFS was performed on the right eye of each. PDLLA/GA membranes were put under the sclera flap for evaluation. GFS with no membrane inserted served as control. Clinical evaluations of intraocular pressure (IOP) and the presence of a filtration bleb were performed at intervals (3 days, 1, 2, 4, 8, 12, 20, and 24 weeks) postoperatively. At each time point, three eyes per group were excised to observe histological changes such as inflammation and scar formation and the expression of collagen type IV, proliferating cell nuclear antigen (PCNA), matrix metalloproteinase-9 (MMP-9), and tissue inhibitor of metalloproteinase-1 (TIMP-1). The expression of connective tissue growth factor (CTGF) mRNA was determined by reverse transcription-polymerase chain reaction.Results The lower IOP level and an effective bleb were maintained for a long time after GFS in the PDLLA/GA group. The histological analysis showed less inflammation and scar formation, weaker expression of collagen type IV and PCNA, more intense MMP-9 and TIMP-1, slightly elevated ratio of MMP-9 and TIMP-1, and a smaller increase in CTGF mRNA postoperatively in the PDLLA/GA group but less than the control group (P<0.05).Conclusion PDLLA/GA membranes may be promising for preventing fibrosis after GFS.

Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis.

Sustained Subconjunctival Delivery of Cyclosporine A Using Thermogelling Polymers for Glaucoma Filtration Surgery.

Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes

Effect of Poly(Dl-Lactide-Co-Glycolide) on Scar Formation after Glaucoma Filtration Surgery

CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.

The PEG-PCL-PEG Hydrogel As an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study.

Target drug delivery system as a new scarring modulation after glaucoma filtration surgery

A novel adjustable PHBV basement film for enhancing the efficacy of glaucoma surgery by inhibiting scar formation

Construction of therapeutic glycopeptide hydrogel as a new substitute for antiproliferative drugs to inhibit postoperative scarring formation

Peptide Hydrogel As an Intraocular Drug Delivery System for Inhibition of Postoperative Scarring Formation

Bio-modulation of Scaring Glaucoma Filtration Surgery Using a Novel Application of Coated Magnesium

Inhibition of Post-Trabeculectomy Fibrosis Via Topically Instilled Antisense Oligonucleotide Complexes Co-Loaded with Fluorouracil.

Evaluating the efficacy and safety of polyglycolic acid-loading mitomycin nanoparticles in inhibiting the scar proliferation after glaucoma filtering surgery

Subconjunctival Sustained Release 5-Fluorouracil for Glaucoma Filtration Surgery

Low Density Lipoprotein - Rosiglitazone - Chitosan-Calcium Alginate/nanoparticles Inhibition of Human Tenon's Fibroblasts Activation and Proliferation

Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.

The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscarring drugs after glaucoma filtration surgery.

Exploration and application of polyhydroxyalkanoates and polylactic acid membranes during glaucoma filtering surgery and interlaminar transplantation in rabbits

Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery

Prevention of filtering surgery failure by subconjunctival injection of a novel peptide hydrogel into rabbit eyes.

[Drug Release and Biocompatibility of Cyclosporine A Drug Delivery System Implanting into the Anterior Chamber].